Skip to main content

NeuroProtective role of HRI following cerebral ischemia

Project description

A targeted therapy for stroke

Stroke occurs when there is a block in the blood supply to a part of the brain. It affects more than one million people every year, and emergency treatments usually involve medication to resolve the blood clots that caused the stroke. Stroke care then on focuses on recovering as much of movement and sensation as possible through rehabilitation. Funded by the Marie Skłodowska-Curie Actions programme, the NeuProHRI project aims to develop a novel therapy for stroke that targets the heme regulated inhibitory (HRI) kinase cellular cascade. Researchers will employ different models of stroke to investigate the pathways that are activated by HRI kinase and test the outcome of compounds on the phenotype of stroke.

Coordinator

FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA
Net EU contribution
€ 165 312,96
Address
Travesa Da Choupana
15706 Santiago De Compostela
Spain

See on map

Region
Galicia A Coruña
Activity type
Research Organisations
Other funding
No data

Partners (1)

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
Net EU contribution
No data
Address
Rue De Tolbiac 101
75654 Paris

See on map

Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Other funding
No data